Condition
Infections Joint Prosthetic
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Enrolling By Invitation1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04297592Phase 4Enrolling By InvitationPrimary
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
NCT06451224CompletedPrimary
Egyptian Arthroplasty Surgeons' Antibiotics Usage Awareness
NCT05902221Phase 3Not Yet RecruitingPrimary
Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections
NCT05604157Not ApplicableUnknownPrimary
Ancef Dosage in Knee Arthroplasty : Tourniquet Clinical Trial
NCT04620395Not ApplicableUnknown
Percutaneous Punch Biopsy for Diagnosis of Septic and Aseptic Prosthetic Joint Failure
Showing all 5 trials